Literature DB >> 9223320

Characterization of tumor necrosis factor-deficient mice.

M W Marino1, A Dunn, D Grail, M Inglese, Y Noguchi, E Richards, A Jungbluth, H Wada, M Moore, B Williamson, S Basu, L J Old.   

Abstract

Although tumor necrosis factor (TNF) initially came to prominence because of its anti-tumor activity, most attention is now focused on its proinflammatory actions. TNF appears to play a critical role in both early and late events involved in inflammation, from localizing the noxious agent and amplifying the cellular and mediator responses at the local site and systemically, to editing (e.g., apoptosis) injured cells or effete immune cells and repairing inflammatory damage. We have generated mice deficient in TNF (TNF-/- mice) and have begun to examine the multiple functions attributed to TNF. TNF-/- mice develop normally and have no gross structural or morphological abnormalities. As predicted, they are highly susceptible to challenge with an infectious agent (Candida albicans), are resistant to the lethality of minute doses of lipopolysaccharide (LPS) following D-galactosamine treatment, have a deficiency in granuloma development, and do not form germinal centers after immunization. Phagocytic activity of macrophages appears relatively normal, as do T cell functions, as measured by proliferation, cytokine release, and cytotoxicity. B cell response to thymus-independent antigens is normal, but the Ig response to thymus-dependent antigen is reduced. Surprisingly, cytokine production induced by LPS appears essentially intact, with the exception of reduced colony-stimulating factor activity. Other unexpected findings coming from our initial analysis are as follows. (i) TNF has low toxicity in TNF-/- mice. (ii) TNF-/- mice show an anomalous late response to heat-killed Corynebacterium parvum. In contrast to the prompt response (granuloma formation, hepatosplenomegaly) and subsequent resolution phase in C. parvum-injected TNF+/+ mice, similarly treated TNF-/- mice show little or no initial response, but then develop a vigorous, disorganized inflammatory response leading to death. These results suggest that TNF has an essential homeostatic role in limiting the extent and duration of an inflammatory process-i.e., an anti-inflammatory function. (iii) In contrast to the expectation that TNF+/+ mice and TNF+/- mice would have identical phenotypes, TNF+/- mice showed increased susceptibility to high-dose LPS lethality, increased susceptibility to Candida challenge, and delayed resolution of the C. parvum-induced inflammatory process, indicating a strong gene dose requirement for different actions of TNF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223320      PMCID: PMC21562          DOI: 10.1073/pnas.94.15.8093

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Unraveling function in the TNF ligand and receptor families.

Authors:  B Beutler; C van Huffel
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

2.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

Authors:  V L Tybulewicz; C E Crawford; P K Jackson; R T Bronson; R C Mulligan
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

3.  Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3.

Authors:  T K Van den Berg; E A Döpp; M R Daha; G Kraal; C D Dijkstra
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

4.  A lymphotoxin-beta-specific receptor.

Authors:  P D Crowe; T L VanArsdale; B N Walter; C F Ware; C Hession; B Ehrenfels; J L Browning; W S Din; R G Goodwin; C A Smith
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

5.  Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.

Authors:  P De Togni; J Goellner; N H Ruddle; P R Streeter; A Fick; S Mariathasan; S C Smith; R Carlson; L P Shornick; J Strauss-Schoenberger
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

6.  Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.

Authors:  J Rothe; W Lesslauer; H Lötscher; Y Lang; P Koebel; F Köntgen; A Althage; R Zinkernagel; M Steinmetz; H Bluethmann
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

7.  Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation.

Authors:  S E Jacobsen; F W Ruscetti; C M Dubois; J R Keller
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

8.  Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.

Authors:  H P Redmond; J Shou; H J Gallagher; C J Kelly; J M Daly
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

9.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Authors:  K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

10.  Development to term of mouse androgenetic aggregation chimeras.

Authors:  J R Mann; C L Stewart
Journal:  Development       Date:  1991-12       Impact factor: 6.868

View more
  226 in total

Review 1.  Biologic therapies in rheumatoid arthritis.

Authors:  K J Bulpitt
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.

Authors:  K B Elkon; C C Liu; J G Gall; J Trevejo; M W Marino; K A Abrahamsen; X Song; J L Zhou; L J Old; R G Crystal; E Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 3.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

4.  Whole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis.

Authors:  Jamie C Merrill; Jian You; Cara Constable; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

5.  TNF alpha is required for hypoxia-mediated right ventricular hypertrophy.

Authors:  R M Smith; J McCarthy; M N Sack
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

Review 6.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

7.  Characterization of the cytokine expression profiles of the aorta and liver of young tumor necrosis factor alpha mutant mice.

Authors:  Yanrong Sun; Miao Yin; Liang Zhang; Jie Pan
Journal:  Mol Cell Biochem       Date:  2012-03-10       Impact factor: 3.396

8.  IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

Authors:  Pamela Gasse; Caroline Mary; Isabelle Guenon; Nicolas Noulin; Sabine Charron; Silvia Schnyder-Candrian; Bruno Schnyder; Shizuo Akira; Valérie F J Quesniaux; Vincent Lagente; Bernhard Ryffel; Isabelle Couillin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Simona Stäger; Clare E Alexander; Amanda C Stanley; Paul M Kaye
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.